Unknown

Dataset Information

Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance.


ABSTRACT: Very high risk neuroblastoma is characterised by increased MAPK signalling, and targeting MAPK signalling is a promising therapeutic strategy. We used a deeply characterised panel of neuroblastoma cell lines and found that the sensitivity to MEK inhibitors varied drastically between these cell lines. By generating quantitative perturbation data and mathematical modelling, we determined potential resistance mechanisms. We found that negative feedbacks within MAPK signalling and via the IGF receptor mediate re-activation of MAPK signalling upon treatment in resistant cell lines. By using cell-line specific models, we predict that combinations of MEK inhibitors with RAF or IGFR inhibitors can overcome resistance, and tested these predictions experimentally. In addition, phospho-proteomic prof

SUBMITTER: Dorel M 

PROVIDER: S-EPMC8604339 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature